Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

UnitedHealth Group, Inc’s. UNH Optum Rx is expanding its offerings for patients with the introduction of two additional HUMIRA biosimilars. Effective Jul 1, Optum Rx will offer three biosimilar ...

The Food and Drug Administration has granted an expanded interchangeable designation for Celltrion’s Yuflyma (adalimumab-aaty), now including prefilled syringe (40mg) and autoinjectors (40mg and 80mg) ...

Alvotech has five approved drugs, including biosimilars of AbbVie's Humira, Johnson & Johnson's Stelara/Simponi, and Eylea. See why ALVO stock is a Strong Buy.

ABBV has rebounded after Humira patent cliff, with Skyrizi and Rinvoq driving growth. Rising estimates and a pipeline set to ...

Prescription medication is a lifeline for millions of people around the U.S. Unfortunately, the cost of such medications has ...

Toni King has authored several books on the subject of Medicare and has appeared regularly as a guest on the American Family Radio Network. You helped me sign up for a Medicare Supplement Plan G and a ...

Jan 12 (Reuters) - AbbVie said on ‌Monday ​that it has ‌struck a three-year deal with U.S. ​President Donald Trump's ...